Injection of recombinant mouse CCL20 into CRC promoted tumor development with a marked recruitment of Treg-cells in wild-type mice, and stimulated tumor growth by directly activating CMT93 cells in CCR6−/− mice. The gene discussed is CCR6; the disease is colorectal carcinoma.